Register and share your invite link to earn from video plays and referrals.

IPO Newsroom
@IPONewsroom_
Your IPO newsroom. S-1 filings, pricing updates, debut coverage, and post-IPO performance.
Joined November 2024
109 Following    31.9K Followers
BAMBUSA THERAPEUTICS PRICES UPSIZED $169 MILLION IPO AT $16, THE MIDPOINT OF ITS RANGE The Boston biotech, built on antibody assets it bought from a BioNTech unit, sold 10.56 million shares, up from 9.38 million planned. $BBTX starts trading on Nasdaq on Friday, per the company.
Show more